NCT02640300 Switching Antipsychotics: Abrupt Discontinuation Versus Overlap Status COMPLETED Phase PHASE4
NCT02639702 Switching From Twice-Daily to Once-Daily Clozapine Dosing in Schizophrenia Status RECRUITING Phase PHASE4
NCT02625103 The Significance of Deviation in Time From the 12-hour Standard Serum-clozapine Monitoring. Status COMPLETED Phase PHASE4
NCT02600741 Family Intervention in Recent Onset Schizophrenia Treatment (FIRST) Status COMPLETED Phase N/A
NCT02562287 Clozapine Versus Other Atypical Antipsychotics for Bipolar Disorder Status UNKNOWN Phase PHASE4
NCT02404155 Biomarker and Safety Study of Clozapine in Patients With Benign Ethnic Neutropenia (BEN) Status COMPLETED Phase NA
NCT01663077 Clozapine Plasma Levels and the Relationship to the Genetic Polymorphism in Shizophrenic Patients Status COMPLETED Phase PHASE4
NCT01498770 An Observational Drug Utilization Study of Asenapine in the United Kingdom (P08308) Status COMPLETED Phase N/A
NCT01448499 Clozapine Versus Amisulpride in Treatment-resistant Schizophrenia Patients Status WITHDRAWN Phase NA
NCT00981526 Telmisartan as an Adjunctive Treatment for Metabolic Problems in Patients With Schizophrenia Status COMPLETED Phase PHASE4
NCT00649844 A Study Comparing the Efficacy and Tolerability of Ziprasidone vs. Clozapine for the Treatment of Schizophrenia in Patients Who Continue to Have Symptoms on or Cannot Tolerate Other Antipsychotic Drugs Status COMPLETED Phase PHASE3
NCT00573287 First Episode Schizophrenia and Cannabis-Related Disorder Study Status COMPLETED Phase NA
NCT00498550 Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual Status COMPLETED Phase PHASE4
NCT00250575 A Study to Evaluate the Safety and Efficacy of Clozapine in Patients With Treatment-resistant Schizophrenia Status COMPLETED Phase PHASE3